This Is MS Multiple Sclerosis Knowledge & Support Community

Thanks for posting this Ian. I was just beginning to wonder if I should continue-this answers that debate!
Lori

FYI this study has a very serious survivorship bias. All this study says to me is that the patients who were doing well on copaxone continued using it. Perhaps those that stopped taking it didn't deteriorate because they stopped taking it, but rather because they had a more serious form of the disease.

I had the same impression reading the results. The methodology seems to be quite uncommon, strange, and I have the impression there could be a bias somewhere...